Revenue for Insulet (PODD)
According to Insulet's latest reported financial statements, the company's current revenue (TTM) is $2.71B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
PODD
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$2.71B
YoY change
+30.7%
5Y CAGR
+24.5%
Peak year (2025)
$2.71B
Cumulative revenue
$13.30B
Revenue history chart for Insulet (PODD) from 2002 to 2025
Revenue history table for Insulet (PODD) from 2002 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $2.71B | +30.7% | ||
| 2024 | $2.07B | +22.1% | ||
| 2023 | $1.70B | +30.0% | ||
| 2022 | $1.31B | +18.8% | ||
| 2021 | $1.10B | +21.5% | ||
| 2020 | $904.40M | +22.5% | ||
| 2019 | $738.20M | +30.9% | ||
| 2018 | $563.82M | +21.6% | ||
| 2017 | $463.77M | +26.4% | ||
| 2016 | $366.99M | +39.1% | ||
| 2015 | $263.89M | -8.6% | ||
| 2014 | $288.72M | +16.9% | ||
| 2013 | $247.08M | +16.9% | ||
| 2012 | $211.37M | +38.8% | ||
| 2011 | $152.25M | +57.0% | ||
| 2010 | $96.97M | +46.8% | ||
| 2009 | $66.03M | +83.1% | ||
| 2008 | $36.06M | +169.7% | ||
| 2007 | $13.37M | +265.1% | ||
| 2006 | $3.66M | +7226.0% | ||
| 2005 | $50,000 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — |
Revenue values are taken from Insulet's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Insulet (PODD) revenue totalled $2.71B – surged 30.7% year-over-year.
Insulet revenue has grown for 10 consecutive years, with a +24.5% compound annual growth rate over 2020–2025 (5 years).
The dataset's maximum revenue sits at $2.71B (2025); the minimum reading of $0 dates to 2002.
Within Healthcare, Insulet (PODD) ranks 9th among 8 peers we track. The peer median for revenue is $65.09B.
Insulet Revenue by Year
Insulet Revenue 2025: $2.71B
Insulet revenue in 2025 was $2.71B, surged 30.7% from 2024. This figure represents the highest annual value in the available history.
Insulet Revenue 2024: $2.07B
Insulet revenue in 2024 was $2.07B, grew 22.1% from 2023.
Insulet Revenue 2023: $1.70B
Insulet revenue in 2023 was $1.70B, surged 30.0% from 2022.
Insulet Revenue 2022: $1.31B
Insulet revenue in 2022 was $1.31B, grew 18.8% from 2021.
Insulet Revenue 2021: $1.10B
Insulet revenue in 2021 was $1.10B.
See more financial history for Insulet (PODD).
Sector peers — Revenue
Companies in the same sector as Insulet, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Insulet's revenue?
- Latest reported revenue for Insulet (PODD) is $2.71B (period ending December 31, 2025).
How has Insulet revenue changed year-over-year?
- Insulet (PODD) revenue changed +30.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Insulet revenue?
- Insulet (PODD) revenue compound annual growth rate is +24.5% over the most recent 5 years available.
When did Insulet revenue hit its highest annual value?
- Insulet revenue reached its highest annual value of $2.71B in 2025.
What was Insulet revenue in 2024?
- Insulet (PODD) revenue in 2024 was $2.07B.
What was Insulet revenue in 2025?
- Insulet (PODD) revenue in 2025 was $2.71B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
PODD Overview
Company profile, financial tools, and key metrics
PODD Revenue Counter
Earns $85.88 every second. See per minute, hour, and day.
PODD Earnings Counter
Earns $7.84 per second net profit. See per minute, hour, and day.
PODD Economic Scale
Exceeds St. Lucia's GDP. Compare with world economies.
PODD What If Invested
What if you had invested $1,000? See historical returns from any date.
PODD How It Makes Money
Discover visual breakdown of $2.71B in revenue — where it comes from and where it goes.
PODD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
PODD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
PODD Daily Price Character
Explosive · 51.5% historical win rate (green days). Streaks & record days.
PODD Buybacks
0.30% TTM buyback yield. Shareholder yield & SBC comparison.